Two potential takeover targets – one public relations related company and one biopharmaceutical company focused on the development of therapies for patients suffering from life-threatening diseases – are among the five low-priced (trading under $10) stocks highlighted in today’s article as having big upside potential to analysts’ price targets. For these five stocks, which may appeal to aggressive traders looking to “get some solid share leverage [and] make money on a much smaller share price move,” CLICK HERE.